Nancy Zhao - Publications

Affiliations: 
Immunology Stanford University Medical School, Palo Alto, CA, United States 

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Zhao NQ, Pi R, Nguyen DN, Ranganath T, Seiler C, Holmes S, Marson A, Blish CA. NKp30 and NKG2D contribute to natural killer recognition of HIV-infected cells. Biorxiv : the Preprint Server For Biology. PMID 38979175 DOI: 10.1101/2024.06.24.600449  0.696
2022 Ivison GT, Vendrame E, Martínez-Colón GJ, Ranganath T, Vergara R, Zhao NQ, Martin MP, Bendall SC, Carrington M, Cyktor JC, McMahon DK, Eron J, Jones RB, Mellors JW, Bosch RJ, et al. Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients. Frontiers in Cellular and Infection Microbiology. 12: 757846. PMID 35223535 DOI: 10.3389/fcimb.2022.757846  0.807
2021 Wilk AJ, Lee MJ, Wei B, Parks B, Pi R, Martínez-Colón GJ, Ranganath T, Zhao NQ, Taylor S, Becker W, Jimenez-Morales D, Blomkalns AL, O'Hara R, Ashley EA, et al. Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19. The Journal of Experimental Medicine. 218. PMID 34128959 DOI: 10.1084/jem.20210582  0.765
2020 Vendrame E, McKechnie JL, Ranganath T, Zhao NQ, Rustagi A, Vergara R, Ivison GT, Kronstad LM, Simpson LJ, Blish CA. Profiling of the Human Natural Killer Cell Receptor-Ligand Repertoire. Journal of Visualized Experiments : Jove. PMID 33283785 DOI: 10.3791/61912  0.665
2020 Zhao NQ, Vendrame E, Ferreira AM, Seiler C, Ranganath T, Alary M, Labbé AC, Guédou F, Poudrier J, Holmes S, Roger M, Blish CA. Natural killer cell phenotype is altered in HIV-exposed seronegative women. Plos One. 15: e0238347. PMID 32870938 DOI: 10.1371/Journal.Pone.0238347  0.817
2020 Wilk AJ, Rustagi A, Zhao NQ, Roque J, Martínez-Colón GJ, McKechnie JL, Ivison GT, Ranganath T, Vergara R, Hollis T, Simpson LJ, Grant P, Subramanian A, Rogers AJ, Blish CA. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nature Medicine. PMID 32514174 DOI: 10.1038/s41591-020-0944-y  0.712
2020 Wilk AJ, Rustagi A, Zhao NQ, Roque J, Martinez-Colon GJ, McKechnie JL, Ivison GT, Ranganath T, Vergara R, Hollis T, Simpson LJ, Grant P, Subramanian A, Rogers AJ, Blish CA. A single-cell atlas of the peripheral immune response to severe COVID-19. Medrxiv : the Preprint Server For Health Sciences. PMID 32511639 DOI: 10.1101/2020.04.17.20069930  0.688
2020 Zhao NQ, Ferreira AM, Grant PM, Holmes S, Blish CA. Treated HIV Infection Alters Phenotype but Not HIV-Specific Function of Peripheral Blood Natural Killer Cells. Frontiers in Immunology. 11: 829. PMID 32477342 DOI: 10.3389/Fimmu.2020.00829  0.681
2020 Ranganath T, Simpson LJ, Ferreira AM, Seiler C, Vendrame E, Zhao N, Fontenot JD, Holmes S, Blish CA. Characterization of the Impact of Daclizumab Beta on Circulating Natural Killer Cells by Mass Cytometry. Frontiers in Immunology. 11: 714. PMID 32391016 DOI: 10.3389/Fimmu.2020.00714  0.772
2020 Ramadoss NS, Zhao NQ, Richardson BA, Grant PM, Kim PS, Blish CA. Enhancing natural killer cell function with gp41-targeting bispecific antibodies to combat HIV infection. Aids (London, England). PMID 32287071 DOI: 10.1097/Qad.0000000000002543  0.631
2020 Vendrame E, Seiler C, Ranganath T, Zhao NQ, Vergara R, Alary M, Labbé AC, Guédou F, Poudrier J, Holmes S, Roger M, Blish CA. TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells. Aids (London, England). PMID 32028328 DOI: 10.1097/Qad.0000000000002488  0.806
2016 Hatton O, Strauss-Albee DM, Zhao NQ, Haggadone MD, Pelpola JS, Krams SM, Martinez OM, Blish CA. NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein-Barr Virus. Frontiers in Immunology. 7: 607. PMID 28018364 DOI: 10.3389/Fimmu.2016.00607  0.725
Show low-probability matches.